213 related articles for article (PubMed ID: 10563177)
1. [Epidemiology of prostatic cancer].
Harvei S
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3589-94. PubMed ID: 10563177
[TBL] [Abstract][Full Text] [Related]
2. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract][Full Text] [Related]
3. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
4. Prostatic cancer: some epidemiological features.
Donn AS; Muir CS
Bull Cancer; 1985; 72(5):381-90. PubMed ID: 3878166
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of prostate cancer part I: descriptive epidemiology.
Brawley OW; Knopf K; Merrill R
Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
Konety BR; Bird VY; Deorah S; Dahmoush L
J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH
Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
[TBL] [Abstract][Full Text] [Related]
8. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
9. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer incidence and survival in relation to education (United States).
Steenland K; Rodriguez C; Mondul A; Calle EE; Thun M
Cancer Causes Control; 2004 Nov; 15(9):939-45. PubMed ID: 15577296
[TBL] [Abstract][Full Text] [Related]
11. Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment.
Stotts RC
Nurs Clin North Am; 2004 Jun; 39(2):327-40. PubMed ID: 15159183
[TBL] [Abstract][Full Text] [Related]
12. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
Roobol MJ; Grenabo A; Schröder FH; Hugosson J
J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
14. Improved survival of patients with prostate cancer in northern Denmark, 1985-2004.
Lund L; Jacobsen J; Borre M; Larsen EH; Graversen PH; Sørensen HT; Nørgaard M;
Scand J Urol Nephrol; 2007; 41(4):308-13. PubMed ID: 17763222
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
Celko AM
Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
[TBL] [Abstract][Full Text] [Related]
16. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
Brenner H; Arndt V
J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
[TBL] [Abstract][Full Text] [Related]
18. Changing demography of prostate cancer in Asia.
Sim HG; Cheng CW
Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
[TBL] [Abstract][Full Text] [Related]
19. [Prostatic cancer in Oslo--a real decline?].
Harvei S; Tretli S; Hagen S
Tidsskr Nor Laegeforen; 1996 Feb; 116(6):750-4. PubMed ID: 8644080
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
Welch HG; Schwartz LM; Woloshin S
J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
